| |
| |
|
| Insider
Information: |
Pickering Grant |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
524,530 |
|
|
Indirect Shares
|
146,054 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
670,584 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Sr VP, Operations |
2005-03-18 |
45,900 |
|
0 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
|
2024-05-01 |
477,847 |
2024-05-01 |
146,054 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director |
2022-03-21 |
783 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
96 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-27 |
4 |
AS |
$22.10 |
$270,637 |
D/D |
(12,246) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-27 |
4 |
OE |
$1.79 |
$21,920 |
D/D |
12,246 |
592,500 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-28 |
4 |
OE |
$1.79 |
$4,754 |
D/D |
2,656 |
582,910 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-05-28 |
4 |
AS |
$22.16 |
$58,857 |
D/D |
(2,656) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-03 |
4 |
AS |
$22.11 |
$154,881 |
D/D |
(7,005) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-03 |
4 |
OE |
$1.79 |
$12,539 |
D/D |
7,005 |
587,259 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-04 |
4 |
OE |
$1.79 |
$14,486 |
D/D |
8,093 |
588,347 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-04 |
4 |
AS |
$22.14 |
$179,179 |
D/D |
(8,093) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-21 |
4 |
OE |
$1.79 |
$1,903 |
D/D |
1,063 |
581,317 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-21 |
4 |
AS |
$22.05 |
$23,439 |
D/D |
(1,063) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-22 |
4 |
OE |
$1.79 |
$132 |
D/D |
74 |
580,328 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-22 |
4 |
AS |
$22.00 |
$1,628 |
D/D |
(74) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-24 |
4 |
OE |
$1.79 |
$24,815 |
D/D |
13,863 |
594,117 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-06-24 |
4 |
AS |
$22.85 |
$320,123 |
D/D |
(13,863) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-07-20 |
4 |
AS |
$22.85 |
$342,686 |
D/D |
(15,000) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-07-20 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
595,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-19 |
4 |
OE |
$1.79 |
$2,382 |
D/D |
1,331 |
581,585 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-19 |
4 |
AS |
$22.40 |
$29,810 |
D/D |
(1,331) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-23 |
4 |
OE |
$1.79 |
$24,468 |
D/D |
13,669 |
593,923 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-08-23 |
4 |
AS |
$22.73 |
$310,722 |
D/D |
(13,669) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-09-21 |
4 |
OE |
$1.79 |
$19,345 |
D/D |
10,807 |
591,061 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-09-21 |
4 |
AS |
$25.17 |
$272,590 |
D/D |
(10,807) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-09-22 |
4 |
OE |
$1.79 |
$7,505 |
D/D |
4,193 |
584,447 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-09-22 |
4 |
AS |
$25.19 |
$105,636 |
D/D |
(4,193) |
580,254 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2021-10-20 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
595,254 |
0 |
- |
|
96 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
